Takada T. Miyazaki M. Miyakawa S. Tsukada K. Nagino M. Kondo S. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas J Hepatobiliary Pancreat Surg 2008 15 2-6 
Tashiro S. Imaizumi T. Ohkawa H. Okada A. Katoh T. Kawarada Y. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan J Hepatobiliary Pancreat Surg 2003 10 345-51 
Rosen C.B. Nagorney D.M. Wiesner R.H. Coffey R.J. Jr Larusso N.F. Cholangiocarcinoma complicating primary sclerosing cholangitis Ann Surg 1991 213 21-5 
Rosen C.B. Nagorney D.M. Cholangiocarcinoma complicating primary sclerosing cholangitis Semin Liver Dis 1991 11 26-30 
Callea F. Sergi C. Fabbretti G. Brisigotti M. Cozzutto C. Medicina D. Precancerous lesions of the biliary tree J Surg Oncol Suppl 1993 3 131-3 
Franco J. Saeian K. Biliary tract inflammatory disorders, primary sclerosing cholangitis and primary biliary cirrhosis Curr Gastroenterol Rep 1999 1 95-101 
Thuluvath P.J. Rai R. Venbrux A.C. Yeo C.J. Cholangiocarcinoma: a review Gastroenterologist 1997 5 306-15 
Yeo C.J. Pitt H.A. Cameron J.L. Cholangiocarcinoma Surg Clin N Am 1990 70 1429-47 
Sugiyama M. Atomi Y. Kuroda A. Muto T. Bile duct carcinoma without jaundice: clues to early diagnosis Hepatogastroenterology 1997 44 1477-83 
Malik I.A. Clinicopathological features and management of gallbladder cancer in Pakistan: a prospective study of 233 cases J Gastroenterol Hepatol 2003 18 950-3 
Al-Quadah M.S. Daradkeh S. Sroujieh A.S. Farah G.R. Masaad J. Gallbladder carcinoma in Jordan Hepatogastroenterology 2005 61 5-7 
Nieveen Van Dijkum E.J. Terwee C.B. Oosterveld P. Meulen J.H. Gouma D.J. Haes J.C. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma Br J Surg 2000 87 110-5 
Kamisawa T. Tu Y. Egawa N. Nakajima H. Horiguchi S. Tsuruta K. Clinicopathologic features of ampullary carcinoma without jaundice J Clin Gastroenterol 2006 40 162-6 
Groen P.C. Gores G.J. LaRusso N.F. Gunderson L.L. Nagorney D.M. Biliary tract cancers New Engl J Med 1999 341 1368-79 
Khan S.A. Thomas H.C. Davidson B.R. Taylor-Robinson S.D. Cholangiocarcinoma Lancet 2005 366 1303-14 
Misra S. Chaturvedi A. Misra N.C. Sharma I.D. Carcinoma of the gallbladder Lancet Oncol 2003 4 167-76 
Piantino P. Fusaro A. Randone A. Cerchier A. Daziano E. Increased levels of CA19-9, CA50 and CA125 in patients with benign disease of biliary tract and the pancreas J Nucl Med Allied Sci 1990 34 97 
Patel A.H. Harnois D.M. Klee G.G. LaRusso N.F. Gores G.J. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis Am J Gastroenterol 2000 95 204-7 
Nichols J.C. Gores G.J. LaRusso N.F. Wiesner R.H. Nagorney D.M. Ritts R.E. Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis Mayo Clin Proc 1993 68 874-9 
Khan S.A. Davidson B.R. Goldin R. Pereira S.P. Rosenbera W.M. Taylor-Robinson S.D. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 2002 51 1-9 
Pasanen P.A. Eskelinen M. Partanen K. Pikkarainen P. Pentill&#228; I. Alhava E. Clinical value of serum tumor markers CEA, CA50 and CA242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study Anticancer Res 1992 12 1687-93 
Han J.K. Choi B.I. Kim A.Y. An S.K. Lee J.W. Kim T.K. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings Radiographics 2002 22 173-87 
Khan S.A. Davidson B.R. Goldin R. Pereria S.P. Rosenbera W.M. Taylor-Robinson S.D. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 2002 51 1-9 
Chen H.W. Pan A.Z. Zhen Z.J. Su S.Y. Wang J.H. Yu S.C. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography AJR Am J Roentgenol 2006 186 1580-6 
Lopera J.E. Soto J.A. Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions Radiology 2001 220 90-6 
Romagnuolo J. Bardou M. Rahme E. Joseph L. Reinhold C. Barkun A.N. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease Ann Intern Med 2003 139 547-57 
Barish M.A. Yocel E.K. Ferrucci J.T. Magnetic resonance cholangiopancreatography New Engl J Med 1999 341 258-64 
Park M.S. Kim T.K. Kim K.W. Perk S.W. Lee J.K. Kim J.S. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP Radiology 2004 233 234-40 
Sakamoto E. Nimura Y. Hayakawa N. Kamiya J. Kondo S. Nagino M. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases Ann Surg 1998 227 405-11 
Hayashi S. Miyazaki M. Kondo Y. Nakajima Nl. Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases Cancer 1994 73 2922-9 
Takada T. Hanyu F. Kobayashi S. Mikoshiba Y. Hamano K. Stefanini P. , Speranza V. Percutaneous transhepatic cholangiodrainage and cholangioscopy for the case of severe obstructive jaundice caused by pancreatic tumor Proceedings of the 18th World Congress of the Int Coll Surg 1973 New York Excerpta Medica Amsterdam American Elsevier 
Nimura Y. Kamiya J. Hayakawa N. Shionoya S. Cholangioscopic differentiation of biliary strictures and polyps Endoscopy 1989 21 1 351-6 
Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy Endoscopy 1993 25 76-80 
Itoi T. Sofuni A. Itokawa F. Tsuchiya T. Kurihara T. Ishii K. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos) Gastrointest Endosc 2007 66 730-6 
Fukuda Y. Tsuyuguchi T. Sakai Y. Tsuchiya S. Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions Gastrointest Endosc 2005 62 374-82 
Sugiyama M. Atomi Y. Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gall bladder lesions: analysis in surgical and follow up series Gut 2000 46 250-4 
Azuma T. Yoshikawa T. Araida T. Takasaki K. Differential diagnosis of polypoid lesion of the gallbladder by endoscopic ultrasonography Am J Surg 2001 181 65-70 
Hirooka Y. Naitoh Y. Goto H. Ito A. Hayakawa S. Watanabe Y. Contrast-enhanced endoscopic ultrasonography in gallbladder diseases Gastrointest Endosc 1998 48 406-10 
Furukawa H. Kosuge T. Shimada K. Yamamoto J. Kanai Y. Mukai K. Small polypoid lesions of the gallbladder Arch Surg 1998 133 735-9 
Kumaran V. Gulati S. Paul B. Pande K. Sahni P. Chattopadhyay K. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder Eur Radiol 2002 12 1993-9 
Kim J.H. Kim T.K. Eun H.W. Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangigraphy, and contrast-enhanced dual phase three dimensional MR angiography J Magn Reson Imaging 2002 16 676-84 
Schwartz L.H. Black J. Fong Y. Jarnagin W. Blumgart L. Gruen D. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography J Comput Assist Tomogr 2002 26 405-10 
Menzel J. Hoepffner N. Sulkowski U. Reimer P. Heinecke A. Poremba C. Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT-a prospective, histopathologically controlled study Gastrointest Endosc 1999 49 349-57 
Itoh A. Goto H. Naitoh Y. Hirooka Y. Furukawa T. Hayakawa Tl. Intraductal ultrasonography in diagnosing tumor extension of cancer of the papilla of Vater Gastrointest Endosc 1997 45 251-60 
Weber S.M. DeMatteo R.P. Fong Y. Blumgart L.H. Jarnagin W.R. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients Ann Surg 2002 235 392-9 
Kondo S. Nimura Y. Hayakawa N. Kamiya J. Nagino M. Uesaka K. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma Br J Surg 2000 87 418-22 
Shimada H. Endo I. Togo S. Nakano A. Izumi T. Nakagawara G. The role of lymph node dissection in the treatment of gallbladder carcinoma Cancer 1997 79 892-9 
Nishio H. Nagino M. Ebata T. Yokoyama Y. Igami T. Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg 2007 14 351-7 
Kitagawa Y. Nagino M. Kamiya J. Uesaka K. Sano T. Yamamoto H. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection Ann Surg 2001 233 385-92 
Poveski S.P. Karpeh M.S. Jr Conlon K.C. Blumgart L.H. Brennan M.F. Association of preoperative biliary drainage with postoperative outcome following pancreatoduodenestomy Ann Surg 1999 230 131-42 
Sewnath M.E. Birjmohum R.S. Rauws E.A. Heiberegtes K. Obertop H. Gouma D.J. The effect of preoperative biliary drainage on postoperative complications after pancreatoduodenectomy J Am Coll Surg 2001 192 726-34 
Martignoni M.E. Wabner M. Kr&#228;hhenb&#252;hl L. Redaelli C.A. Friess H. B&#252;cher M.W. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy Am J Surg 2001 181 52-9 
Pisters P.W. Hudec W.A. Hess K.R. Lee J.E. Vauthey J.N. Lahoti S. Effect of preoperative biliary decompression on pancreatoduodenectomy. Associated morbidity in 300 consecutive patients Ann Surg 2001 234 47-55 
Takada T. Is preoperative biliary drainage necessary according to evidence-based medicine? J Hepatobiliary Pancreat Surg 2001 8 58-64 
Nagino M. Kamiya J. Uesaka K. Sano T. Yamamoto H. Hayakawa K. Complications of hilar cholangiocarcinoma World J Surg 2001 25 1277-83 
Farges O. Belghiti J. Kianmanesh R. Regimbeau J.M. Santoro R. Vilgrain V. Portal vein embolization before right hepatectomy: prospective clinical trial Ann Surg 2003 237 208-17 
Hemming A.W. Reed A.I. Fujita S. Foley D.P. Howard R.J. Surgical management of hilar cholangiocarcinoma Ann Surg 2005 241 693-9 
Seyama Y. Kubota K. Sano K. Noie T. Takayama T. Kosuge T. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate Ann Surg 2003 238 73-83 
Kawasaki S. Imamura H. Kobayashi A. Noike T. Miwa S. Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization Ann Surg 2003 238 84-92 
Kondo S. Hirano S. Ambo Y. Tanaka E. Okushiba S. Morikawa T. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study Ann Surg 2004 240 95-101 
Sano T. Shimada K. Sakamoto Y. Yamamoto J. Yamasaki S. Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality Ann Surg 2006 244 240-7 
Nagino M. Kamiya J. Nishio H. Ebata T. Arai T. Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up Ann Surg 2006 243 364-72 
Nimura Y. Hayakawa N. Kamiya J. Kondo S. Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus World J Surg 1990 14 535-43 
Gazzaniga G.M. Filauro M. Bagarolo C. Mori L. Surgery for hilar cholangiocarcinoma: Italian experience J Hepatobiliary Pancreat Surg 2000 7 122-7 
Lee S.G. Lee Y.J. Park K.M. Hwang S. Min P.C. One hundred and eleven liver resections for hilar bile duct cancer J Hepatobiliary Pancreat Surg 2000 7 135-41 
Su C.H. Tsay S.H. Wu C.C. Shyr Y.M. King K.L. Lee C.H. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma Ann Surg 1996 223 384-94 
Kayahara M. Nagakawa T. Ohta T. Kitagawa H. Tajima H. Miwa K. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer Ann Surg 1999 229 76-83 
Jang J.Y. Kim S.W. Park D.J. Ahn Y.J. Yoon Y.S. Choi M.G. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection Ann Surg 2005 241 77-84 
Ebata T. Watanabe H. Ajioka Y. Oda K. Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma Br J Surg 2002 89 1260-7 
Ebata T. Nagino M. Kamiya J. Uesaka K. Nagasaka T. Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases Ann Surg 2003 238 720-7 
Miyazaki M. Kato A. Ito H. Kimura F. Shimizu H. Ohtsuka M. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 2007 141 581-8 
Suzuki T. Yoshidome H. Kimura F. Shimizu H. Ohtsuka M. Kato A. Renal function is well maintained after use of left renal vein graft for vascular reconstruction in hepatobiliary-pancreatic surgery J Am Coll Surg 2006 202 87-92 
Hemming A.W. Kim R.D. Mekeel K.L. Fujita S. Reed A.I. Foley D.P. Portal vein resection for hilar cholangiocarcinoma Am Surg 2006 72 599-604 
Nimura Y. Hayakawa N. Kamiya J. Maeda S. Kondo S. Yasui A. Combined portal vein and liver resection for carcinoma of the biliary tract Br J Surg 1991 78 727-31 
Miyazaki M. Itoh H. Ambiru S. Shimizu H. Togawa A. Gohchi E. Radical surgery for advanced gallbladder carcinoma Br J Surg 1996 83 478-81 
Kondo S. Nimura Y. Hayakawa N. Kamiya J. Nagino M. Uesaka K. Extensive surgery for carcinoma of the gallbladder Br J Surg 2002 89 179-84 
Klein P. Reingruber B. Kastl S. Dworak O. Hohenberger W. Is local excision of pT1-ampullary carcinomas justified? Eur J Surg Oncol 1996 22 366-71 
Paramythiotis D. Kleeff J. Wirtz M. Friess H. B&#252;chler M.W. Still any transduodenal local excision in tumors of the papilla of Vater? J Hepatobiliary Pancreat Surg 2004 11 239-44 
Beger H.G. Treitschke F. Gansauge F. Harada N. Hiki N. Mattfeldt T. Tumor of the ampulla of Vater Arch Surg 1999 134 526-32 
Todoroki T. Iwasaki Y. Orii K. Otsuka M. Ohara K. Kawamoto T. Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma World J Surg 1991 15 357-66 
Todoroki T. Kawamoto T. Otsuka M. Koike N. Yoshida S. Takada Y. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer Hepatogastroenterology 1999 46 1585-91 
Gonz&#225;lez Gonz&#225;lez D. Gerard J.P. Maners A.W. Lande-Guyaux B. Dijk-Milatz A. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor) Semin Liver Dis 1990 10 131-41 
Langer J.C. Langer B. Taylor B.R. Zeldin R. Cummings B. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach Surgery 1985 98 752-9 
Stein D.E. Heron D.E. Rosato E.L. Anne P.R. Topham A.K. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy Am J Clin Oncol 2005 28 21-3 
Speer A.G. Cotton P.B. Russell R.C. Mason R.R. Hatfield A.R. Leung J.W. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice Lancet 1987 2 57-62 
Smith A.C. Dowsett J.F. Russell R.C. Hatfield A.R. Cotton P.B. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction Lancet 1994 344 1655-60 
Davids P.H. Groen A.K. Rauws E.A. Tytgat G.N. Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction Lancet 1992 340 1488-92 
Kaassis M. Boyer J. Dumas R. Ponchon T. Coumaros D. Delcenserie R. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study Gastrointest Endosc 2003 57 178-82 
Levy M.J. Baron T.H. Gostout C.J. Petersen B.T. Farnell M.B. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach Clin Gastroenterol Hepatol 2004 2 273-85 
Hausegger K.A. Thurnher S. Bodend&#246;rfer G. Zollikofer C.L. Uggowitzer M. Kugler C. Treatment of malignant biliary obstruction with polyurethane-covered Wallstents AJR Am J Roentgenol 1998 170 403-8 
Isayama H. Komatsu Y. Tsujino T. Sasahira N. Hirano K. Toda N. A prospective randomised study of &#8220;covered&#8221; versus &#8220;uncovered&#8221; diamond stents for the management of distal malignant biliary obstruction Gut 2004 53 729-34 
Wagner H.J. Knyrim K. Vakil N. Klose K.J. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial Endoscopy 1993 25 213-6 
Glimelius B. Hoffman K. Sj&#246;d&#233;n P.O. Jacobsson G. Sellstr&#246;m H. Enander L.K. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 1996 7 593-600 
Takada T. Nimura Y. Katoh H. Nagakawa T. Nakayama T. Matsushiro T. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for nonresectable pancreatic and biliary carcinoma: multicenter randomized trial Hepatogastroenterology 1998 45 2020-6 
Ishii H. Furuse J. Yonemoto N. Nagase M. Yoshino M. Sato T. Chemotherapy in the treatment of advanced gallbladder cancer Oncology 2004 66 138-42 
Okusaka T. Ishii H. Funakoshi A. Yamao K. Ohkawa S. Saito S. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Cancer Chemother Pharmacol 2006 57 647-53 
Grove M.K. Hermann R.E. Vogt D.P. Broughan T.A. Role of radiation after operative palliation in cancer of the proximal bile ducts Am J Surg 1991 161 454-8 
Tollenaar R.A. Velde C.J. Taat C.W. Gonzalez Gonzalez D. Leer J.W. Hermans J. External radiotherapy and extrahepatic bile duct cancer Eur J Surg 1991 157 587-9 
Ortner M.E. Caca K. Berr F. Liebetruth J. Mansmann U. Huster D. Voderholzer W. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study Gastroenterology 2003 125 1355-63 
Zoepf T. Jakobs R. Arnold J.C. Apel D. Riemann J.F. Palliation of nonresectable bile duct cancer: Improved survival after photodynamic therapy Am J Gastroenterol 2005 100 2426-30 
DeLoach SS Appel LJ Chen J Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency Cohort Am J Hypertens 2009 22 1235-1241 
Gahl WA Thoene JG Schneider JA Cystinosis N Engl J Med 2002 347 111-121 
Go AS Chertow GM Fan D McCulloch CE Hsu CY Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 2004 351 1296-1305 
Hogg RJ Furth S Lemley KV National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification Pediatrics 2003 111 1416-1421 
Holewijn S Heijer M Swinkels DW Stalenhoef AF Graaf J The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis J Clin Endocrinol Metab 2009 94 2893-2899 
Jatoi NA Mahmud A Bennett K Feely J Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques J Hypertens 2009 27 2186-2191 
Juonala M Kahonen M Laitinen T Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study Eur Heart J 2008 29 1198-1206 
K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 2004 43 S1-290 
Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 1999 130 461-470 
Mattace-Raso FU Hofman A Verwoert GC Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values' Eur Heart J 2010 31 2338-2350 
Mourad JJ Pannier B Blacher J Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension Kidney Int 2001 59 1834-1841 
Murphy JL Papathakis PC Hypercholesterolemia in children with cystinosis Pediatr Nephrol 1993 7 159-162 
Nesterova G Gahl W Nephropathic cystinosis: late complications of a multisystemic disease Pediatr Nephrol 2008 23 863-878 
Simon A Gariepy J Chironi G Megnien JL Levenson J Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk J Hypertens 2002 20 159-169 
Smulyan H Asmar RG Rudnicki A London GM Safar ME Comparative effects of aging in men and women on the properties of the arterial tree J Am Coll Cardiol 2001 37 1347-1380 
Stein JH Korcarz CE Hurst RT Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine J Am Soc Echocardiogr 2008 21 93-111 
Town M Jean G Cherqui S A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis Nat Genet 1998 18 319-324 
Ueda M O'Brien K Rosing DR Ling A Kleta R McAreavey D Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation Clin J Am Soc Nephrol 2006 1 555-562 
Wang MC Tsai WC Chen JY Huang JJ Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease Am J Kidney Dis 2005 45 494-501 
Wilkinson IB MacCallum H Flint L Cockcroft JR Newby DE Webb DJ The influence of heart rate on augmentation index and central arterial pressure in humans J Physiol 2000 525 Pt 1 263-270 
Yasmin BMJ Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness Q J Med 1999 92 595-600 
Yilmaz MI Qureshi AR Carrero JJ Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease Am J Nephrol 2010 31 214-221 
Prater JM Olshemski FC Adult intussusception Am Fam Physician 1993 47 447-452 
Agha FP Intussusception in adults AJR Am J Roentgenol 1986 146 527-531 
Nagle R Lymphangiomatous hamartoma with intussusception of the caput caeci Br J Surg 1968 55 879-880 
Matsui A Okajima K Ishii M Namio H Kawanishi M Fujii Y Lymphangioma of the cecum with intussusceptions: a case report and review of literature J Jpn Pract Surg Soc 1986 47 234-239 
Wan YL Lee TY Hung CF Ng KK Ultrasound and CT findings of a cecal lymphangioma presenting with intussusception Eur J Radiol 1998 27 77-79 
Matsuba Y Mizuiri H Murata T Niimi K Adult intussusception due to lymphangioma of the colon J Gastroenterol 2003 38 181-185 
Kim TO Lee JH Kim GH Heo J Kang DH Song GA Adult intussusception caused by cystic lymphangioma of the colon: a rare case report World J Gastroenterol 2006 12 2130-2132 
Kuramoto S Sakai S Tsuda K Kaminishi M Ihara O Oohara T Lymphangioma of the large intestine: report of a case Dis Colon Rectum 1988 31 900-905 
Losanoff JE Richman BW El-Sherif A Rider KD Jones JW Mesenteric cystic lymphangioma J Am Coll Surg 2003 196 598-603 
Azar T Berger DL Adult intussusception Ann Surg 1997 226 134-138 
Lorigan JG DuBrow RA The computed tomographic appearances and clinical significance of intussusception in adults with malignant neoplasms Br J Radiol 1990 63 257-262 
Hatada T Ikeda H Tanigawa A Fujiwara Y Hanada Y Yamamura T Lymphangioma of the colon: a case report and review of the Japanese literature Acta Gastroenterol Belg 2000 63 239-241 
Kochman ML Wiersema MJ Hawes RH Canal D Wiersema L Preoperative diagnosis of cystic lymphangioma of the colon by endoscopic ultrasound Gastrointest Endosc 1997 45 204-206 
Saftlas AF Olson DR Franks AL Atrash HK Pokras R Epidemiology of preeclampsia and eclampsia in the United States, 1979&#8211;1986 Am J Obstet Gynecol 1990 163 460-465 
Hubel CA Kozlov AV Kagan VE Evans RW Davidge ST McLaughlin MK Roberts JM Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress Am J Obstet Gynecol 1996 175 692-700 
Oudejans CBM van Dijk M Osterkamp M Lachmeijer A Blankenstein MA Genetics of preeclampsia: paradigm shifts Hum Genet 2007 120 607-612 
Zintzaras E Kitsios G Harrison GA Laivuori H Kivinen K Kere J Messinis I Stefanidis I Ioannidis JPA Heterogeneity-based genome search meta-analysis for preeclampsia Hum Genet 2006 120 360-370 
Kabi BC Goel N Rao YN Tripathy R Tempe A Thakur AS Levels of erythrocyte malonyldialdehyde, vitamin E, reduced glutathione, G6PD activity and plasma urate in patients of pregnancy induced hypertension Indian J Med Res 1994 100 23-25 
Higgs GA Vane JR Inhibition of cyclo-oxygenase and lipoxygenase Br Med Bull 1983 39 265-270 
Zusterzeel PL Peters WH Visser W Hermsen KJ Roelofs HM Steegers EA A polymorphism in the gene for microsomal epoxide hydrolase is associated with preeclampsia J Med Genet 2001 38 234-237 
Panburana P Phuapradit W Puchaiwatananon O Antioxidant nutrients and lipid peroxide levels in Thai preeclamptic pregnant women J Obstet Gynaecol Res 2000 26 377-381 
Ozan H Ilcol Y Kimya Y Cengiz C Ediz B Plasma antioxidant status and lipid profile in non-gravida women with a history of pre-eclampsia J Obstet Gynaecol Res 2002 28 274-279 
Lachmeijer AMA Dekker GA Pals G Aarnoudse JG Ten Kate LP Arngr&#237;msson R Searching for preeclampsia genes:the current position Eur J Obstet Gynecol Rep Biol 2002 105 94-113 
M&#252;tze S Rudnik-Sch&#246;neborn S Zerres K Rath W Genes and the preeclampsia syndrome J Perinat Med 2008 36 38-58 
Seidegard J Ekstrom G The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics Environ Health Perspect 1997 105 791-799 
Zusterzeel PL Peters WH De Bruyn MA Knapen MF Merkus HM Steegers EA Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies Obstet Gynecol 1999 94 1033-1038 
Zusterzeel PL Visser W Peters WH Merkus HW Nelen WL Steegers EA Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia Obstet Gynecol 2000 96 50-54 
Watson MA Stewart RK Smith GB Massey TE Bell DA Human glutathione S-transferase P1 polymorphisms:relationship to lung tissue enzyme activity and population frequency distribution Carcinogenesis 1998 19 275-280 
Zusterzeel PL te Morsche R Raijmakers MT Roes EM Peters WH Steegers EA Paternal contribution to the risk for pre-eclampsia J Med Genet 2002 39 44-45 
Vatish M Randeva HS Grammatopoulos DK Hormonal regulation of placental nitric oxide and pathogenesis of preeclampsia Trends Mol Med 2006 12 223-233 
Serrano NC Casas JP D&#237;az LA Pa&#225;ez C Mesa CM Cifuentes R Monterrosa A Bautista A Hawe E Hingorani AD Endothelial NO synthase genotype and risk of preeclampsia:a multicenter case-control study Hypertension 2004 44 702-707 
Yu CK Casas JP Savvidou MD Sahemey MK Nicolaides KH Hingorani AD Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia:a case-control study and a meta-analysis BMC Pregnancy Childbirth 2006 6 7 
Yoshimura T Chowdhury FA Yoshimura M Okamura H Genetic and environmental contributions to severe preeclampsia:lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country Gynecol Obstet Invest 2003 56 10-13 
H&#228;kli T Romppanen EL Hiltunen M Helisalmi S Punnonen K Heinonen S Endothelial nitric oxide synthase polymorphism in preeclampsia J Soc Gynecol Investig 2003 10 154-157 
Landau R Xie H-G Dishy V Wood AJJ Stein CM Smiley RM No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia Am J Hypertens 2004 17 391-394 
Savvidou MD Vallance PJ Nicolaides KH Hingorani AD Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy Hypertension 2001 38 1289-1293 
Brunzell JD Scriver CR , Beaudet AL , Sly WS , Valle D Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome The metabolic basis of inherited disease 1995 7th ed New York McGraw-Hill 1913-1932 
Hayden MR Ma Y Molecular genetics of lipoprotein lipase deficiency Mol Cell Biochem 1990 113 171-176 
Foubert L Benlian P Turpin G Lipoprotein lipase:a multifunctional enzyme in lipoprotein metabolism Presse Med 1996 25 207-210 
Yang W-S Nevin DN Peng R Brunzell JD Deeb SS A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity Proc Natl Acad Sci USA 1995 92 4462-4466 
Yang W-S Nevin DN Iwasaki L Peng R Brown BG Brunzell JD Deeb SS Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease J Lipid Res 1996 37 2627-2637 
Hubel CA Roberts JM Ferrell RE Association of preeclampsia with common coding sequence variations in the lipoprotein lipase gene Clin Genet 1999 4 289-296 
Kim YJ Williamson RA Chen K Smith JL Murray JL Merill DC Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia Hypertension 2001 38 992-996 
Cnattingius S Reilly M Pawitan Y Lichtenstein P Maternal and fetal genetic factors account for most of familiar aggregation of preeclampsia:a population-based Swedish cohort study Am J Med Genet 2004 130A 365-371 
Lie RT Rasmussen S Brunborg H Gjessing HK Lie-Nielsen E Irgens LM Fetal and maternal contributions to risk of pre-eclampsia:population based study BMJ 1998 316 1343-1347 
GOPEC Consortium Disentangling fetal and maternal susceptibility for pre-eclampsia:a British multicenter candidate-gene study Am J Hum Genet 2005 77 127-131 
The Genetics of Pre-eclampsia (GOPEC) Consortium Babies, pre-eclamptic mothers and grandparents:a three-generation phenotyping study J Hypertens 2007 25 849-854 
Zhang Z Jia L Hou L Xiong P Wu X Wang X Huang Y Ke H Chang C Cui S Analysis of TAP1 and TAP2 polymorphism of mother-infant in Chinese patients with preeclampsia Cell Mol Immunol 2005 2 141-144 
Skj&#230;rven R Vatten L Wilcox A R&#248;nning T Irgens L Lie RT Recurrence of preeclampsia across generations:exploring fetal and maternal genetic components in a population based cohort BMJ 2005 331 877 
Tan CY Ho JFV Chong YS Loganath A Chan YH Ravichandran J Lee CG Chong SS Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies Mol Hum Reprod 2008 14 317-324 
Spielman RS McGinnis RE Ewens WJ Transmission test for linkage disequilibrium:the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 1993 52 506-516 
Arngrimsson R Bjornsson S Geirsson RT Bjornsson H Walker JJ Snaedal G Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population Br J Obstet Gynaecol 1990 9 762-769 
Reimer T Koczan D Gerber B Richter D Thiesen HJ Friese K Microarray analysis of differentially expressed genes in placental tissues of pre-eclampsia:up-regulation of obesity-related genes Mol Hum Reprod 2002 8 674-680 
Heikilla A Tuomisto T Hakkinen S-K Keski-Nisula L Heinonen S Yla-Herttuala S Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia &#8211; an array study on case-specific human preeclamptic placental tissue Acta Obstet Gynecol Scand 2005 84 679-689 
Esplin MS Fausett MB Fraser A Kerber R Mineau G Carrillo J Varner MW Paternal and maternal components of the predisposition to preeclampsia N Eng J Med 2001 344 867-872 
Arngrimsson R Purandare S Connor M Walker JJ Bj&#246;rnsson S Soubrier F Kotelevtsev YV Geirsson RT Bj&#246;rnsson H Angiotensinogen:a candidate gene involved in preeclampsia? Nat Genet 1993 2 114-115 
Cetin M Pinarbasi E Percin FE Akg&#252;n E Percin S Pinarbasi H Gurlek F Cetin A No association of polymorphisms in the ghutathione S-transferase genes with preeclampsia, eclampsia and HELLP syndrome in a Turkish population J Obstet Gynaecol Res 2005 31 236-241 
Ali-Osman F Akande O Antoun G Mao JX Buolamwini J Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins J Biol Chem 1997 15 10004-10012 
Lieshout EM Roelofs HM Dekker S Mulder CJ Wobbes T Jansen JB Peters WH Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma Cancer Res 1999 3 586-589 
Gebhardt GS Peters WH Hillermann R Odendaal HJ Carelse-Tofa K Raijmakers MT Steegers EA Maternal and fetal single nucleotide polymorphisms in the epoxide hydrolase and gluthatione S-transferase P1 genes are not associated with pre-eclampsia in the coloured population of the Western Cape, South Africa J Obstet Gynaecol 2004 24 866-872 
Ohta K Kobashi G Hata A Yamada H Minakami H Fujimoto S Kondo K Tamashiro H Association between a variant of the glutathione S-transferase P1 gene (GSTP1) and hypertension in pregnancy in Japanese:interaction with parity, age, and genetic factors Semin Thromb Hemost 2003 6 653-659 
Kosmas IP Tatsioni A Ioannidis JP Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and preeclampsia:a meta-analysis J Hypertens 2004 22 1655-1662 
Prasmusinto D Skrablin S Fimmers R van der Ven K Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene Eur J Obstet Gynecol Reprod Biol 2004 112 162-169 
Tempfer CB Dorman K Deter RL O&#8217;Brien WE Gregg AR An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia Hypertens Pregnancy 2001 20 107-118 
Medica I Kastrin A Peterlin B Genetic polymorphisms in vasoactive genes and preeclampsia:a meta-analysis Eur J Obstet Gynecol Reprod Biol 2007 131 115-126 
Descamps OS Bruniaux M Guilmot P-F Tonglet R Heller F Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children J Lipid Res 2005 46 2405-2414 
Adiels M Taskinen MR Packard C Caslake MJ Soro-Paavonen A Westerbacka J Vehkavaara S Hakkinen A Olfsson SO Yki-Jarvinen H Boren J Overproduction of large VLDL particles is driven by increased liver fat content in man Diabetologia 2006 49 755-765 
Basu SK Goldstein JL Brown MS Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts J BioPhys Chem 1978 253 3852-3856 
Brown MS Goldstein JL Receptor-mediated endocytosis: insights from the lipoprotein receptor system Proc Natl Acad Sci USA 1979 76 3330-3337 
Chan DC Watts GF Redgrave TG Mori TA Barrett PHR Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration Metabolism Clin Exp 2002 51 1041-1046 
Cohn JS Johnson EJ Millar JS Cohn SD Milne RW Marcel YL Russell RM Schaefer EJ Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters J Lipid Res 1993 34 2033-2040 
Dunn KW McGraw TE Maxfield FR Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome J Cell Biol 1989 109 3303-3314 
Goldstein JL Anderson RGW Brown MS Coated pits, coated vesicles and receptor-mediated endocytosis Nature 1979 279 679-685 
Harwood HJ Pellarin LD Kinetics of low-density lipoprotein receptor activity in Hep-G2 cells: derivation and validation of a Briggs-Haldane-based kinetic model for evaluating receptor-mediated endocytotic processes in which receptors recycle Biochem J 1997 323 649-659 
Havekes LM De Wit ECM Princen HMG Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity J Biochem 1987 247 739-746 
Jackson KG Maitin V Leake DS Yaqoob P Williams CM Saturated fat induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells J Lipid Res 2006 47 393-403 
Prestera T. Zhang Y. Spencer S. R. Wilczak C. A. Talalay P. Adv. Enzyme Regul. 1993 33 
Bereiter-Hahn J. Jendrach M. Int. Rev. Cell Mol. Biol. 2010 284 
Kraaij M. D. Savage N. D. van der Kooij S. W. Koekkoek K. Wang J. van den Berg J. M. Ottenhoff T. H. Kuijpers T. W. Holmdahl R. van Kooten C. Gelderman K. A. Proc. Natl. Acad. Sci. U. S. A. 2010 107 
Talalay P. Dinkova-Kostova A. T. Holtzclaw W. D. Adv. Enzyme Regul. 2003 43 
Marnett L. J. Riggins J. N. West J. D. J. Clin. Invest. 2003 111 
Paulsen C. E. Carroll K. S. ACS Chem. Biol. 2010 5 
Die Krankhaften Geschwulste August Hirschwald Berlin 1863&#8722;1867 
Nathan C. Nature 2002 420 
Nishino H. Nishino A. Takayasu J. Hasegawa T. Iwashima A. Hirabayashi K. Iwata S. Shibata S. Cancer Res. 1988 48 
Huang M. T. Ho C. T. Wang Z. Y. Ferraro T. Lou Y. R. Stauber K. Ma W. Georgiadis C. Laskin J. D. Conney A. H. Cancer Res. 1994 54 
Suh N. Wang Y. Honda T. Gribble G. W. Dmitrovsky E. Hickey W. F. Maue R. A. Place A. E. Porter D. M. Spinella M. J. Williams C. R. Wu G. Dannenberg A. J. Flanders K. C. Letterio J. J. Mangelsdorf D. J. Nathan C. F. Nguyen L. Porter W. W. Ren R. F. Roberts A. B. Roche N. S. Subbaramaiah K. Sporn M. B. Cancer Res. 1999 59 
Connolly J. D. Hill R. A. Nat. Prod. Rep. 2010 27 , and previous reviews in this series
Ovesna Z. Vachalkova A. Horvathova K. Tothova D. Neoplasma 2004 51 
Liu J. J. Ethnopharmacol. 1995 49 
Liu J. J. Ethnopharmacol. 2005 100 
Honda T. Rounds B. V. Gribble G. W. Suh N. Wang Y. Sporn M. B. Bioorg. Med. Chem. Lett. 1998 8 
Tetrahedron Lett. 1992 33 , and private communication from Dr. Chung Solvolytic Displacement Reactions McGraw-Hill New York 1962 13 
Honda T. Honda Y. Favaloro F. G. Jr. Gribble G. W. Suh N. Place A. E. Rendi M. H. Sporn M. B. Bioorg. Med. Chem. Lett. 2002 12 
Natural Products Chemistry Kodansha Ltd., Toyko, University Science Books Mill Valley, CA 1983 3 187-187 
Kushiro T. Shibuya M. Ebizuka Y. J. J. Am. Chem. Soc. 1999 121 
Abe I. Sakano Y. Sodeyama M. Tanaka H. Noguchi H. Shibuya M. Ebizuka Y. J. Am. Chem. Soc. 2004 126 
Phillips D. R. Rasbery J. M. Bartel B. Matsuda S. P. Curr. Opin. Plant Biol. 2006 9 
Shi B. Greaney M. F. Chem. Commun. 2005 
Li W. W. Heinze J. Haehnel W. J. Am. Chem. Soc. 2005 127 
Steert K. El-Sayed I. Van der Veken P. Krishtal A. Van Alsenoy C. Westrop G. D. Mottram J. C. Coombs G. H. Augustyns K. Haemers A. Bioorg. Med. Chem. Lett. 2007 17 
Dinkova-Kostova A. T. Massiah M. A. Bozak R. E. Hicks R. J. Talalay P. Proc. Natl. Acad. Sci. U. S. A. 2001 98 
Naidu B. N. Sorenson M. E. Bronson J. J. Pucci M. J. Clark J. M. Ueda Y. Bioorg. Med. Chem. Lett. 2005 15 Kumar A. Akanksha Tetrahedron 2007 63 Chu C.-M. Gao S. Sastry M. N. V. Yao C.-F. Tetrahedron Lett. 2005 46 Karodia N. Liu X. Ludley P. Pletsas D. Stevenson G. Tetrahedron 2006 62 
Surendra K. Krishnaveni N. S. Sridhar R. Rao K. R. Tetrahedron Lett. 2006 47 Duan Z. Xuan X. Li T. Yang C. Wu Y. Tetrahedron Lett. 2006 47 Karodia N. Liu X. Ludley P. Pletsas D. Stevenson G. Tetrahedron 2006 62 
Nising C. F. Br&#228;se S. Chem. Soc. Rev. 2008 37 Karodia N. Liu X. Ludley P. Pletsas D. Stevenson G. Tetrahedron 2006 62 
Couch R. D. Browning R. G. Honda T. Gribble G. W. Wright D. L. Sporn M. B. Anderson A. C. Bioorg. Med. Chem. Lett. 2005 15 
Honda T. Gribble G. W. Suh N. Finlay H. J. Rounds B. V. Bore L. Favaloro F. G. Jr. Wang Y. Sporn M. B. J. Med. Chem. 2000 43 
Green N. M. Adv. Protein Chem. 1975 29 Billingsley M. L. Pennypacker K. R. Hoover C. G. Kincaid R. L. Biotechniques 1987 5 For the biotinylation of retinoids, see: Nesnas N. Rando R. R. Nakanishi K. Tetrahedron 2002 58 
Honda T. Janosik T. Honda Y. Han J. Liby K. T. Williams C. R. Couch R. D. Anderson A. C. Sporn M. B. Gribble G. W. J. Med. Chem. 2004 47 
Ikeda T. Sporn M. Honda T. Gribble G. W. Kufe D. Cancer Res. 2003 63 
Konopleva M. Tsao T. Ruvolo P. Stiouf I. Estrov Z. Leysath C. E. Zhao S. Harris D. Chang S. Jackson C. E. Munsell M. Suh N. Gribble G. Honda T. May W. S. Sporn M. B. Andreeff M. Blood 2002 99 
Ito Y. Pandey P. Place A. Sporn M. B. Gribble G. W. Honda T. Kharbanda S. Kufe D. Cell Growth Differ. 2000 11 
Dinkova-Kostova A. T. Liby K. T. Stephenson K. K. Holtzclaw W. D. Gao X. Suh N. Williams C. Risingsong R. Honda T. Gribble G. W. Sporn M. B. Talalay P. Proc. Natl. Acad. Sci. U. S. A. 2005 102 
Liby K. Hock T. Yore M. M. Suh N. Place A. E. Risingsong R. Williams C. R. Royce D. B. Honda T. Honda Y. Gribble G. W. Hill-Kapturczak N. Agarwal A. Sporn M. B. Cancer Res. 2005 65 
Tanaka Y. Aleksunes L. M. Goedken M. J. Chen C. Reisman S. A. Manautou J. E. Klaassen C. D. Toxicol. Appl. Pharmacol. 2008 231 
Liby K. T. Yore M. M. Sporn M. B. Nat. Rev. Cancer 2007 7 
Yore M. M. Liby K. T. Honda T. Gribble G. W. Sporn M. B. Mol. Cancer Ther. 2006 5 
Ahmad R. Raina D. Meyer C. Kharbanda S. Kufe D. J. Biol. Chem. 2006 281 
Liby K. Voong N. Williams C. R. Risingsong R. Royce D. B. Honda T. Gribble G. W. Sporn M. B. Letterio J. J. Clin. Cancer Res. 2006 12 
Ahmad R. Raina D. Meyer C. Kufe D. Cancer Res. 2008 68 
Liby K. Risingsong R. Royce D. B. Williams C. R. Yore M. M. Honda T. Gribble G. W. Lamph W. W. Vannini N. Sogno I. Albini A. Sporn M. B. Clin. Cancer Res. 2008 14 
Pitha-Rowe I. Liby K. Royce D. Sporn M. Invest. Ophthalmol. Vis. Sci. 2009 50 
To C. Kulkarni S. Pawson T. Honda T. Gribble G. W. Sporn M. B. Wrana J. L. Di Guglielmo G. M. J. Biol. Chem. 2008 283 
To C. Shilton B. H. Di Guglielmo G. M. J. Biol. Chem. 2010 285 
Yang L. Calingasan N. Y. Thomas B. Chaturvedi R. K. Kiaei M. Wille E. J. Liby K. T. Williams C. Royce D. Risingsong R. Musiek E. S. Morrow J. D. Sporn M. Beal M. F. PLoS One 2009 4 
O'Hara M Swain A Rates and risk of postpartum depression: a meta-analysis Int Rev Psychiatry 1996 8 37-54 
Goodman SH Brogan D Lynch ME Fielding B Social and emotional competence in children of depressed mothers Child Dev 1993 64 516-531 
Murray L Sinclair D Cooper P The socioemotional development of 5-year-old children of postnatally depressed mothers J Child Psychol Psychiatry 1999 40 1259-1271 
Paulson JF Bazemore SD Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis J Am Med Assoc 2010 303 1961-1969 
Ramchandani PG O'Connor TG Evans J The effects of pre- and post-natal depression in fathers: a natural experiment comparing the effects of exposure to depression on offspring J Child Psychol Psychiatry 2008 49 1069-1078 
Ramchandani PG Stein A O'Conner TG Depression in men in the postnatal period and later child psychopathology: a population cohort study J Am Acad Child Adolesc Psychiatry 2008 47 390-398 
Paulson JF Keefe HA Leiferman JA Early parental depression and child language development J Child Psychol Psychiatry 2009 50 254-262 
Cummings EM Keller PS Davies PT Towards a family process model of maternal and paternal depressive symptoms: exploring multiple relations with child and family functioning J Child Psychol Psychiatry 2005 46 479-489 
Kouros CD Cummings EM Transactional relations between marital functioning and depressive symptoms Am J Orthopsychiatry 2011 81 128-138 
Johnson SL Jacob T Sequential interactions in the marital communication of depressed men and women J Consult Clin Psychol 2000 68 4-12 
Papp LM Goeke-Morey MC Cummings EM Links between spouses' psychological distress and marital conflict in the home J Fam Psychol 2007 21 533-537 
Madsen SA Juhl T Paternal depression in the postnatal period assessed with traditional and male depression scales Int J Mens Health Gender 2007 4 26-31 
Cox JL Holden JM Sagovsky R Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale Br J Psychiatry 1987 150 782-786 
Edmondson OJ Psychogiou L Vlachos H Depression in fathers in the postnatal period: assessment of the Edinburgh Postnatal Depression Scale as a screening measure J Affect Disord 2010 125 365-368 
Gorman LL O'Hara MW Figueiredo B Adaptation of the structured clinical interview for DSM-IV disorders for assessing depression in women during pregnancy and post-partum across countries and cultures Br J Psychiatry Suppl 2004 46 s17-s23 
Gaynes BN Gavin N Meltzer-Brody S Perinatal depression: prevalence, screening accuracy, and screening outcomes Evid Rep Technol Assess (Summ) 2005 1-8 
Matthey S Barnett B Kavanagh DJ Howie P Validation of the Edinburgh Postnatal Depression Scale for men, and comparison of item endorsement with their partners J Affect Disord 2001 64 175-184 
Babor TF Higgins-Biddle JC Saunders JB Monteiro MG AUDIT: The Alcohol Use Disorders Identification Test 2001 Geneva, Switzerland World Health Organization 
Boschloo L Vogelzangs N Smit JH The performance of the Alcohol Use Disorder Identification Test (AUDIT) in detecting alcohol abuse and dependence in a population of depressed or anxious persons J Affect Disord 2010 126 441-446 
Spanier GB The measurement of marital quality J Sex Marital Ther 1979 5 288-300 
Hooley JM Teasdale JD Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism J Abnorm Psychol 1989 98 229-235 
Gartstein MA Rothbart MK Studying infant temperament via the Revised Infant Behavior Questionnaire Infant Behav Dev 2003 26 64-86 
Hanington L Ramchandani P Stein A Parental depression and child temperament: assessing child to parent effects in a longitudinal population study Infant Behav Dev 2010 33 88-95 
Murray L Fiori-Cowley A Hooper R Cooper P The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome Child Dev 1996 67 2512-2526 
Ramchandani P Psychogiou L Paternal psychiatric disorders and children's psychosocial development Lancet 2009 374 646-653 
Goodman S Gotlib I Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission Psychol Rev 1999 106 458-490 
Keller PS Cummings EM Peterson KM Davies PT Marital conflict in the context of parental depressive symptoms: implications for the development of children's adjustment problems Soc Dev 2009 18 536-555 
Kouros CD Papp LM Cummings EM Interrelations and moderators of longitudinal links between marital satisfaction and depressive symptoms among couples in established relationships J Fam Psychol 2008 22 667-677 
Stein A Lehtonen A Harvey AG Nicol-Harper R Craske M The influence of postnatal psychiatric disorder on child development. Is maternal preoccupation one of the key underlying processes? Psychopathology 2009 42 11-21 
Schacht PM Cummings EM Davies PT Fathering in family context and child adjustment: a longitudinal analysis J Fam Psychol 2009 23 790-797 
Kane P Garber J The relations among depression in fathers, children's psychopathology, and father-child conflict: a meta-analysis Clin Psychol Rev 2004 24 339-360 
Aguilar R Gil L Gray JA Driscoll P Flint J Dawson GR Fearfulness and sex in F2 Roman rats: Males display more fear though both sexes share the same fearfulness traits Physiology and Behavior 2003 78 723-732 
Andersen SL Trajectories of brain development: Point of vulnerability or window of opportunity? Neuroscience and Biobehavioral Reviews 2003 27 3-18 
Arakawa H Interaction between isolation rearing and social development on exploratory behavior in male rats Behavioural Processes 2005 70 223-234 
Beatty WW Fessler RG Ontogeny of sex differences in open-field behavior and sensitivity to electric shock in the rat Physiology and Behavior 1976 16 413-417 
Bertoglio LJ Carobrez AP Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety Behavioural Brain Research 2000 108 197-203 
Bronstein PM Open-field behavior of the rat as a function of age: Cross-sectional and longitudinal investigations Journal of Comparative and Physiological Psychology 1972 80 335-341 
Brown GR Nemes C The exploratory behaviour of rats in the hole-board task: Is head-dipping a valid measure of neophilia? Behavioural Processes 2008 78 442-448 
Candland DK Campbell BA Development of fear in the rat as measured by behavior in the open field Journal of Comparative and Physiological Psychology 1962 55 593-598 
Carobrez AP Bertoglio LJ Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on Neuroscience and Biobehavioral Reviews 2005 29 1193-1205 
Crabbe JC Morris RGM Festina lente: Late-night thoughts on high-throughput screening of mouse behavior Nature Neuroscience 2004 7 1175-1179 
Crick NR Zahn-Waxler C The development of psychopathology in females and males: Current progress and future challenges Development and Psychopathology 2003 15 719-742 
Doremus TL Brunell SC Varlinskaya EI Spear LP Anxiogenic effects during withdrawl from acute ethanol in adolescent and adult rats Pharmacology, Biochemistry and Behavior 2003 75 411-418 
Doremus TL Varlinskaya EI Spear LP Age-related differences in elevated plus maze behavior between adolescent and adult rats Annals of the New York Academy of Sciences 2004 1021 427-430 
Doremus TL Varlinskaya EI Spear LP Factor analysis of elevated plus-maze behavior in adolescent and adult rats Pharmacology, Biochemistry and Behavior 2006 83 570-577 
Doremus-Fitzwater TL Varlinskaya EI Spear LP Effects of pretest manipulation on elevated plus-maze behavior in adolescent and adult male and female Sprague-Dawley rats Pharmacology, Biochemistry and Behavior 2009a 92 413-423 
Doremus-Fitzwater TL Varlinskaya EI Spear LP Social and non-social anxiety in adolescent and adult rats after repeated restraint Physiology and Behavior 2009b 97 484-494 
Elliott BM Faraday MM Phillips JM Grunberg NE Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adults rats Pharmacology, Biochemistry and Behaviour 2004 77 21-28 
Estanislau C Morato S Behavior ontogeny in the elevated plus-maze: Prenatal stress effects International Journal of Developmental Neuroscience 2006 24 255-262 
Gabriel SM Roncancio JR Ruiz NS Growth hormone pulsatility and the endocrine milieu during sexual maturation in male and female rats Neuroendocrinology 1992 56 619-628 
Grewel SS Shepherd JK Bill DJ Fletcher A Dourish CT Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats Psychopharmacology 1997 133 29-38 
Hall CS Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality Journal of Comparative Psychology 1934 18 385-403 
Hall CS Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity Journal of Comparative Psychology 1936 22 345-352 
Hammad TA Laughren T Racoosin J Suicidality in pediatric patients treated with antidepressant drugs Archives of General Psychiatry 2006 63 332-339 
Handley SL Mithani S Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of &#8216;fear&#8217;-motivated behaviour Naunyn-Schmiedeberg's Archives of Pharmacology 1984 327 1-5 
Hayward C Sanborn K Puberty and the emergence of gender differences in psychopathology Journal of Adolescent Health 2002 30S 49-58 
Hefner K Holmes A An investigation of the behavioral actions of ethanol across adolescence in mice Psychopharmacology 2007 191 311-322 
Hogg S A review of the validity and variability of the elevated plus-maze as an animal model of anxiety Pharmacology, Biochemistry and Behavior 1996 54 21-30 
Hughes RN Intrinsic exploration in animals: Motives and measures Behavioural Processes 1997 41 213-226 
Imhof JT Coelho ZMI Schmitt ML Morato GS Carobrez AP Influence of gender and age on performance of rats in the elevated plus maze apparatus Behavioural Brain Research 1993 56 177-180 
Johnston AL File SE Sex differences in animal tests of anxiety Physiology and Behavior 1991 49 245-250 
Knorr DW Vanha-Perttula T Lipsett MB Structure and function of rat testis through pubescence Endocrinology 1970 86 1298-1304 
Leussis MP Anderson SL Is adolescence a sensitive period for depression? Behavioral and neuroanatomical findings from a social stress model Synapse 2008 62 22-30 
Litvin Y Pentkowski NS Pobbe RL Blanchard DC Blanchard RJ Blanchard RJ , Blanchard DC , Griebel G , Nutt D Unconditioned models of fear and anxiety Handbook of anxiety and fear 2008 Amsterdam Academic Press 81-99 
Lupien SJ McEwen BS Gunnar MR Heim C Effects of stress throughout the lifespan on the brain, behaviour and cognition Nature Reviews Neuroscience 2009 10 434-445 
Lynn DA Brown GR The ontogeny of exploratory behaviour in male and female adolescent rats (Rattus norvegicus) Developmental Psychobiology 2009 51 513-520 
Macri S Adriani W Chiarotti F Laviola G Risk taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice Animal Behaviour 2002 64 541-546 
Malkesman O Pine DS Tragon T Austin SR Henter ID Chen G Animal models of suicide-trait-related behaviors Trends in Pharmacological Sciences 2009 30 165-173 
Masur J Schutz MT Boerngen R Gender differences in open-field behavior as a function of age Developmental Psychobiology 1980 13 107-110 
McCormick CM Mathews IZ HPA function in adolescence: Role of sex hormones in its regulation and the enduring consequences of exposure to stressors Pharmacology, Biochemistry and Behaviour 2007 86 220-233 
McCormick CM Smith C Mathews IZ Effects of chronic social stress in adolescence on anxiety and neuroendocrine response to mild stress in male and female rats Behavioural Brain Research 2008 187 228-238 
Montgomery KC The relation between fear induced by novel stimulation and exploratory behavior Journal of Comparative and Physiological Psychology 1955 48 254-260 
Paus T Keshavan M Giedd JN Why do many psychiatric disorders emerge during adolescence? Nature Reviews Neuroscience 2008 9 947-957 
Petersen AC Adolescent development Annual Review of Psychology 1988 39 583-607 
Philpot RM Wecker L Dependence of adolescent novelty-seeking behavior on response phenotype and effects of apparatus scaling Behavioral Neuroscience 2008 122 861-875 
Prut L Belzung C The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review European Journal of Pharmacology 2003 463 3-33 
Ray J Hansen S Temperament in the rat: Sex differences and hormonal influences on harm avoidance and novelty seeking Behavioral Neuroscience 2004 118 488-497 
Reardon LE Leen-Feldner EW Hayward C A critical review of the empirical literature on the relation between anxiety and puberty Clinical Psychology Review 2009 29 1-23 
Roman E Arborelius L Male but not female Wistar rats show increased anxiety-like behaviour in response to bright light in the defensive withdrawal test Behavioural Brain Research 2009 202 303-307 
Romeo RD Neuroendocrine and behavioral development during puberty: A tale of two axes Vitamins and Hormones 2005 71 1-25 
Romeo RD Adolescence: A central event in shaping stress reactivity Developmental Psychobiology 2010 52 244-253 
Sanborn K Hayward C Hayward C Hormonal changes at puberty and the emergence of gender difference in internalizing disorders Gender differences at puberty 2003 Cambridge Cambridge University Press 29-58 
Slawecki CJ Comparison of anxiety-like behavior in adolescent and adult Sprague-Dawley rats Behavioral Neuroscience 2005 119 1477-1483 
Slob AK Huizer T van der Werff ten Boesch JJ Ontogeny of sex differences in open-field ambulation in the rat Physiology and Behavior 1986 37 313-315 
Spear LP The adolescent brain and age-related behavioral manifestations Neuroscience and Biobehavioral Reviews 2000a 24 417-463 
Spear LP Neurobehavioral changes in adolescence Current Directions in Psychological Science 2000b 9 111-114 
Spear LP Assessment of adolescent neurotoxicology: Rationale and methodological considerations Neurotoxicology and Teratology 2007 29 1-9 
Stansfield KH Kirstein CL Effects of novelty on behavior in the adolescent and adult rat Developmental Psychobiology 2006 48 10-15 
Stewart J Skvarenina A Pottier J Effects of neonatal androgens on open-field behavior and maze learning in the prepubescent and adult rat Physiology and Behavior 1975 14 291-295 
Stone EA Quartermain D Greater behavioral effects of stress in immature as compared to mature male mice Physiology and Behavior 1997 63 143-145 
Swanson HH Sex differences in behaviour of hamsters in open field and emergence tests: Effects of pre- and post-pubertal gonadectomy Animal Behaviour 1966 14 522-529 
Tentler JJ LaPaglia N Steiner J Williams D Castelli M Kelley MR Ethanol, growth hormone and testosterone in peripubertal rats Journal of Endocrinology 1997 152 477-487 
Tirelli E Laviola G Adriani W Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents Neuroscience and Biobehavioral Reviews 2003 27 163-178 
Vila JL Philpot RM Kirstein CL Grid crossings: Inability to compare activity levels between adolescent and adult rats Annals of the New York Academy of Sciences 2004 1021 418-421 
Walf AA Frye CA The use of the elevated plus maze as an assay of anxiety-related behavior in rodents Nature Protocols 2007 2 322-328 
Yang X-M Gorman AL Dunn AJ The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats Journal of Pharmacology and Experimental Therapeutics 1999 255 1064-1070 
Zanato VF Martins MP Anselmo-Franci JA Petenusci SO Lamano-Carvalho TL Sexual development of male Wistar rats Brazilian Journal of Medical and Biological Research 1994 27 1273-1280 
Zimmerberg B Farley MJ Sex differences in anxiety behavior in rats: Role of gonadal hormones Physiology and Behavior 1993 54 1119-1124 
Hu FB Diet and lifestyle influences on risk of coronary heart disease Curr Atheroscler Rep 2009 11 257-263 
Sahyoun NR Lentzner H Hoyert D Robinson KN Trends in causes of death among the elderly Aging Trends 2001 1-10 
Anderson KM Wilson PW Odell PM Kannel WB An updated coronary risk profile. A statement for health professionals Circulation 1991 83 356-362 
Anderson KM Odell PM Wilson PW Kannel WB Cardiovascular disease risk profiles Am Heart J 1991 121 293-298 
de Rojas FD De Frutos T Ponte A Chacon JM Vitale GC Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study Prev Cardiol 2009 12 65-71 
Melo-Filho J Multiple risk factor intervention trial (MRFIT) Revista Brasileira de Hipertens&#227;o 1998 5 48-52 
Grundy SM Cleeman JI Daniels SR Donato KA Eckel RH Franklin BA Gordon DJ Krauss RM Savage PJ Smith SC Jr Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 2005 112 2735-2752 
Grundy SM Metabolic syndrome: a multiplex cardiovascular risk factor J Clin Endocrinol Metab 2007 92 399-404 
Grundy SM Brewer HB Jr Cleeman JI Smith SC Jr Lenfant C Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 2004 109 433-438 
Stampfer MJ Hu FB Manson JE Rimm EB Willett WC Primary prevention of coronary heart disease in women through diet and lifestyle N Engl J Med 2000 343 16-22 
Knoops KT de Groot LC Kromhout D Perrin AE Moreiras-Varela O Menotti A van Staveren WA Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project Jama 2004 292 1433-1439 
Yusuf S Hawken S Ounpuu S Dans T Avezum A Lanas F McQueen M Budaj A Pais P Varigos J Lisheng L Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 2004 364 937-952 
de Oliveira EP Manda RM Torezan GA Corrente JE Burini RC Dietary, anthropometric, and biochemical determinants of plasma high-density lipoprotein-cholesterol in free-living adults Cholesterol 2011 2011 851750 
Takahashi MM de Oliveira EP Moreto F Portero-McLellan KC Burini RC Association of dyslipidemia with intakes of fruit and vegetables and the body fat content of adults clinically selected for a lifestyle modification program Arch Latinoam Nutr 2010 60 148-154 
da Conceicao Ferreira CC Peixoto Mdo R Barbosa MA Silveira EA Prevalence of cardiovascular risk factors in elderly individuals treated in the Brazilian Public Health System in Goiania Arq Bras Cardiol 2010 95 621-628 
Pimentel GD Portero-McLellan KC de Oliveira EP Spada AP Oshiiwa M Zemdegs JC Barbalho SM Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance Nutr Res 2010 30 186-190 
Avezum A Piegas LS Pereira JC Risk factors associated with acute myocardial infarction in the Sao Paulo metropolitan region: a developed region in a developing country Arq Bras Cardiol 2005 84 206-213 
Sanibal E Torres E Sanibal C Mello A Damasceno N Associa&#231;&#227;o entre nutrientes da dieta e fatores de risco cardiovascular Rev Bras Alim Nutr: J Brazilian Soc Food Nutr 2009 34 71-84 
IBGE Instituto Brasileiro de Geografia e Estat&#237;stica. Estimativas da popula&#231;&#227;o residente em munic&#237;pios brasileiros. Minist&#233;rio do Planejamento, Or&#231;amento e Estat&#237;stica, 2006 [acesso em 12 de junho de 2008, dispon&#237;vel em http://www.ibge.gov.br/home/estatistica/populacao/estimativa2006/estimativa.shtm 
V Diretrizes Brasileiras de Hipertens&#227;o Arterial Revista da Sociedade Brasileira de Cardiologia 2005 84 
I Diretriz Brasileira de Diagn&#243;stico e Tratamento da S&#237;ndrome Metab&#243;lica Arq Bras Cardiol 2005 84 Suplemento I 
IV Diretriz Brasileira Sobre Dislipidemias e Preven&#231;&#227;o da Aterosclerose, Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia Arq Bras Cardiol 2007 88 
Diagnosis and classification of diabetes mellitus Diabetes Care 2004 27 Suppl 1 S5-S10 
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) Jama 2001 285 2486-2497 
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 3143-3421 
Heyward VH Stolarczyk LM Avalia&#231;&#227;o da Composi&#231;&#227;o Corporal Aplicada Barueri: Manole 2000 
WHO Report of a joint FAO/WHO Consultation. Preparation and use of food-based Dietary Guidelines 2002 Geneva: World Health Organization 
Segal KR Van Loan M Fitzgerald PI Hodgdon JA Van Itallie TB Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study Am J Clin Nutr 1988 47 7-14 
An approach to the classification and evaluation of obesity Obesity 1992 
Janssen I Heymsfield SB Baumgartner RN Ross R Estimation of skeletal muscle mass by bioelectrical impedance analysis J Appl Physiol 2000 89 465-471 
Janssen I Baumgartner RN Ross R Rosenberg IH Roubenoff R Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women Am J Epidemiol 2004 159 413-421 
Fisberg RM Slater B Marchioni DML Martini LA Inqu&#233;ritos Alimentares - M&#233;todos e Bases Cient&#237;ficos Barueri: Manole 2005 
NEPA/UNICAMP Tabela brasileira de composi&#231;&#227;o de alimentos. Taco. Vers&#227;o 1. Campinas 2004 
Philippi ST Tabela de Composi&#231;&#227;o de Alimentos: Suporte para decis&#227;o nutricional 2002 2 S&#227;o Paulo 
Mota JF Rinaldi AEM Pereira AF Maest&#225; N Scarpin MM Burini RC Adaptation of the healthy eating index to the food guide of the Brazilian population Rev Nutri 2008 21 545-552 
Philippi ST Latterza AR Cruz ATR Ribeiro LC Adapted food pyramid: a guide for a right food choice Rev Nutri 1999 12 65-80 
Wannamethee SG Shaper AG Lennon L Morris RW Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus Arch Intern Med 2005 165 2644-2650 
Ford ES The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study Atherosclerosis 2004 173 309-314 
Malik S Wong ND Franklin SS Kamath TV L'Italien GJ Pio JR Williams GR Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 2004 110 1245-1250 
Dekker JM Girman C Rhodes T Nijpels G Stehouwer CD Bouter LM Heine RJ Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study Circulation 2005 112 666-673 
Lakka HM Laaksonen DE Lakka TA Niskanen LK Kumpusalo E Tuomilehto J Salonen JT The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men Jama 2002 288 2709-2716 
Coutinho Tde A Turner ST Peyser PA Bielak LF Sheedy PF Kullo IJ Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis Am J Hypertens 2007 20 83-89 
Culleton BF Larson MG Kannel WB Levy D Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 1999 131 7-13 
Niskanen LK Laaksonen DE Nyyssonen K Alfthan G Lakka HM Lakka TA Salonen JT Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study Arch Intern Med 2004 164 1546-1551 
Moriarity JT Folsom AR Iribarren C Nieto FJ Rosamond WD Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 2000 10 136-143 
Strasak A Ruttmann E Brant L Kelleher C Klenk J Concin H Diem G Pfeiffer K Ulmer H Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men Clin Chem 2008 54 273-284 
Darlington L Platelet adhesiveness in gout Postgrad Med J 1973 49 4-26 
Emmerson B Atherosclerosis and urate metabolism Austr NZJ Med 1979 9 451-454 
Powers SK Kavazis AN DeRuisseau KC Mechanisms of disuse muscle atrophy: role of oxidative stress Am J Physiol Regul Integr Comp Physiol 2005 288 R337-344 
Dhalla NS Temsah RM Netticadan T Role of oxidative stress in cardiovascular diseases J Hypertens 2000 18 655-673 
Weinbrenner T Cladellas M Isabel Covas M Fito M Tomas M Senti M Bruguera J Marrugat J High oxidative stress in patients with stable coronary heart disease Atherosclerosis 2003 168 99-106 
Boniface DR Tefft ME Dietary fats and 16-year coronary heart disease mortality in a cohort of men and women in Great Britain Eur J Clin Nutr 2002 56 786-792 
Esrey KL Joseph L Grover SA Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study J Clin Epidemiol 1996 49 211-216 
Jakobsen MU Overvad K Dyerberg J Schroll M Heitmann BL Dietary Fat and Risk of Coronary Heart Disease: Possible Effect Modification by Gender and Age Am J Epidemiol 2004 160 141-149 
Hu FB Manson JE Willett WC Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review J Am Coll Nutr 2001 20 5-19 
Hu FB Stampfer MJ Manson JE Rimm E Colditz GA Rosner BA Hennekens CH Willett WC Dietary fat intake and the risk of coronary heart disease in women N Engl J Med 1997 337 1491-1499 
Song MJ Kim KH Yoon JM Kim JB Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes Biochem Biophys Res Commun 2006 346 739-745 
Libby P Inflammation in atherosclerosis Nature 2002 420 868-874 
Libby P Ridker PM Maseri A Inflammation and atherosclerosis Circulation 2002 105 1135-1143 
Jenkins DJA Kendall CWC Vuksan V Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial Am J Clin Nutr 2002 75 834-839 
Vuksan V Jenkins DJ Spadafora P Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes: a randomized controlled metabolic trial Diabetes Care 1999 22 913-919 
Pereira MA Jacobs DJ Jr Pins JJ The effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults Am J Clin Nutr 2002 75 848-855 
Pereira MA O'Reilly E Augustsson K Dietary Fiber and Risk of Coronary Heart Disease. A Pooled Analysis of Cohort Studies Arch Intern Med 2004 164 370-376 
Rimm EB Ascherio A Giovannucci E Spiegleman D Stampfer MJ Willett WC Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men JAMA 1996 275 447-451 
Liu S Buring JE Sesso HD Rimm EB Willett WC Manson JE A prospective study of dietary fiber intake and risk of cardiovascular disease among women J Am Coll Cardiol 2002 39 49-56 
Pietinen P Rimm EB Korhonen P Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Circulation 1996 94 2720-2727 
Kushi LH Meyer KA Jacobs DR Jr Cereals, legumes, and chronic disease risk reduction: evidence from epidemiologic studies Am J Clin Nutr 1999 70 451S-458S 
Willett WC Howe GR Kushi LH Adjustment for total energy intake in epidemiologica studies Am J Clin Nutr 1997 65 supl l S1220-S1228 
Ara&#250;jo NC Barton V Jones M Stocks PA Ward SA Davies J Bray PG Shone AE Cristiano ML O'Neill PM Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates Bioorg Med Chem Lett 2009 19 2038-2043 
Atamna H Ginsburg H The malaria parasite supplies glutathione to its host cell: investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum Eur J Biochem 1997 250 670-679 
Barends M Jaidee A Khaohirun N Singhasivanon P Nosten F In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border Malar J 2007 6 81 
Basco LK Dechy-Cabaret O Ndounga M Meche FS Robert A Meunier B In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates Antimicrob Agents Chemother 2001 45 1886-1888 
Becker K Rahlfs S Nickel C Schirmer RH Glutathione: functions and metabolism in the malarial parasite Plasmodium falciparum Biol Chem 2003 384 551-566 
Bejon P Lusingu J Olotu A Leach A Lievens M Vekemans J Mshamu S Lang T Gould J Dubois MC Demoitie MA Stallaert JF Vansadia P Carter T Njuguna P Awuondo KO Malabeja A Abdul O Gesase S Mturi N Drakeley CJ Savarese B Villafana T Ballou WR Cohen J Riley EM Lemnge MM Marsh K von Seidlein L Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age N Engl J Med 2008 359 2521-2532 
Benoit-Vical F Lelievre J Berry A Deymier C Dechy-Cabaret O Cazelles J Loup C Robert A Magnaval JF Meunier B Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes Antimicrob Agents Chemother 2007 51 1463-1472 
Biot C Dessolin J Ricard I Dive D Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates J Organomet Chem 2004 689 4678-4682 
Biot C Pradines B Sergeant MH Gut J Rosenthal PJ Chibale K Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues Bioorg Med Chem Lett 2007 17 6434-6438 
Bloland PB Drug resistance in malaria 2001 Geneva WHO, Malaria Epidemiology Branch, Centers for Disease Control and Prevention 1-23 
Bray PG Martin RE Tilley L Ward SA Kirk K Fidock DA Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance Mol Microbiol 2005 56 323-333 
Burgess SJ Selzer A Kelly JX Smilkstein MJ Riscoe MK Peyton DH A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum J Med Chem 2006 49 5623-5625 
Capela R Oliveira R Goncalves LM Domingos A Gut J Rosenthal PJ Lopes F Moreira R Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition Bioorg Med Chem Lett 2009 19 3229-3232 
Chipeleme A Gut J Rosenthal PJ Chibale K Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum Bioorg Med Chem 2007 15 273-282 
Chiyanzu I Clarkson C Smith PJ Lehman J Gut J Rosenthal PJ Chibale K Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives Bioorg Med Chem 2005 13 3249-3261 
Cosl&#233;dan F Fraisse L Pellet A Guillou F Mordmuller B Kremsner PG Moreno A Mazier D Maffrand JP Meunier B Selection of a trioxaquine as an antimalarial drug candidate Proc Natl Acad Sci USA 2008 105 17579-17584 
Creek DJ Charman WN Chiu FCK Prankerd RJ Dong Y Vennerstrom JL Charman SA Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials Antimicrob Agents Chemother 2008 52 1291-1296 
Davioud-Charvet E Delarue S Biot C Schw&#246;bel B Boehme CC M&#252;ssigbrodt A Maes L Sergheraert C Grellier P Schirmer RH Becker K A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline J Med Chem 2001 44 4268-4276 
Eckstein-Ludwig U Webb RJ Van Goethem ID East JM Lee AG Kimura M O'Neill PM Bray PG Ward SA Krishna S Artemisinins target the SERCA of Plasmodium falciparum Nature 2003 424 957-961 
Ellis GL Amewu R Hall C Rimmer K Ward SA O'Neill PM An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity Bioorg Med Chem Lett 2008 18 1720-1724 
Foley M Tilley L Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents Pharmacol Ther 1998 79 55-87 
Gautam A Ahmed T Batra V Paliwal J Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials Curr Drug Metab 2009 10 289-306 
G&#243;mez ZM Rathod PK Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice Antimicrob Agents Chemother 1990 34 1371-1375 
Jones M Mercer AE Stocks PA La Pensee LJ Cosstick R Park BK Kennedy ME Piantanida I Ward SA Davies J Bray PG Rawe SL Baird J Charidza T Janneh O O'Neill PM Antitumour and antimalarial activity of artemisinin-acridine hybrids Bioorg Med Chem Lett 2009 19 2033-2037 
Kelly JX Smilkstein MJ Cooper RA Lane KD Johnson RA Janowsky A Dodean RA Hinrichs DJ Winter R Riscoe M Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum Antimicrob Agents Chemother 2007 51 4133-4140 
Kelly JX Smilkstein MJ Brun R Wittlin S Cooper RA Lane KD Janowsky A Johnson RA Dodean RA Winter R Hinrichs DJ Riscoe MK An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity Nature 2009 459 270-273 
Kouznetsov VV G&#243;mez-Barrio A Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation Eur J Med Chem 2009 44 3091-3113 
Loup C Lelievre J Benoit-Vical F Meunier B Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine Antimicrob Agents Chemother 2007 51 3768-3770 
Maher B Malaria: the end of the beginning Nature 2008 451 1042-1046 
Maude RJ Woodrow CJ White LJ The artemisinin antimalarials: preserving the &#8220;magic bullet.&#8221; Drug Dev Res 2010 71 12-19 (this issue)
Meierjohann S Walter RD Muller S Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum Biochem J 2002 368 761-768 
Meshnick SR Yang YZ Lima V Kuypers F Kamchonwongpaisan S Yuthavong Y Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu) Antimicrob Agents Chemother 1993 37 1108-1114 
Morphy R Rankovic Z Designed multiple ligands. An emerging drug discovery paradigm J Med Chem 2005 48 6523-6543 
Muregi FW Kano S Kino H Ishih A Plasmodiumberghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model Exp Parasitol 2009 121 376-380 
Noedl H Se Y Schaecher K Smith BL Socheat D Fukuda MM Evidence of artemisinin-resistant malaria in western Cambodia N Engl J Med 2008 359 2619-2620 
Nzila A The past, present and future of antifolates in the treatment of Plasmodium falciparum infection J Antimicrob Chemother 2006 57 1043-1054 
Nzila A Ward SA Marsh K Sims PF Hyde JE Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy Trends Parasitol 2005 21 292-298 
Olliaro P Wells TN The global portfolio of new antimalarial medicines under development Clin Pharmacol Ther 2009 85 584-595 
Olson JE Lee GK Semenov A Rosenthal PJ Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors Bioorg Med Chem 1999 7 633-638 
Pandey AV Tekwani BL Singh RL Chauhan VS Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite J Biol Chem 1999 274 19383-19388 
Perry CS Charman SA Prankerd RJ Chiu FC Dong Y Vennerstrom JL Charman WN Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarials J Pharm Sci 2006 95 737-747 
Pukrittayakamee S Chotivanich K Chantra A Clemens R Looareesuwan S White NJ Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria Antimicrob Agents Chemother 2004 48 1329-1334 
Raji&#263; Z Kos G Zorc B Singh PP Singh S Macromolecular prodrugs. XII. Primaquine conjugates: synthesis and preliminary antimalarial evaluation Acta Pharm 2009 59 107-115 
Rathod PK G&#243;mez ZM Plasmodiumyoelii: oral delivery of 5-fluoroorotate to treat malaria in mice Exp Parasitol 1991 73 512-514 
Rathod PK Khatri A Hubbert T Milhous WK Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro Antimicrob Agents Chemother 1989 33 1090-1094 
Rathod PK Leffers NP Young RD Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum Antimicrob Agents Chemother 1992 36 704-711 
Robert A Meunier B Is alkylation the main mechanism of action of the antimalarial drug artemisinin? Chem Soc Rev 1998 27 273-279 
Rosenthal PJ Antimalarial drug discovery: old and new approaches J Exp Biol 2003 206 3735-3744 
Sabbani S Stocks PA Ellis GL Davies J Hedenstrom E Ward SA O'Neill PM Piperidine dispiro-1,2,4-trioxane analogues Bioorg Med Chem Lett 2008 18 5804-5808 
Sajid M McKerrow JH Cysteine proteases of parasitic organisms Mol Biochem Parasitol 2002 120 1-21 
Solomon VR Haq W Smilkstein M Srivastava K Rajakumar S Puri SK Katti SB Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline Med Chem 2008 4 446-456 
Uhlemann AC Wittlin S Matile H Bustamante LY Krishna S Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277) Antimicrob Agents Chemother 2007 51 667-672 
Vangapandu S Sachdeva S Jain M Singh S Singh PP Kaul CL Jain R 8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents Bioorg Med Chem 2003 11 4557-4568 
Van Schalkwyk DA Egan TJ Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum Drug Resist Updat 2006 9 211-226 
Vennerstrom JL Arbe-Barnes S Brun R Charman SA Chiu FC Chollet J Dong Y Dorn A Hunziker D Matile H McIntosh K Padmanilayam M Santo Tomas J Scheurer C Scorneaux B Tang Y Urwyler H Wittlin S Charman WN Identification of an antimalarial synthetic trioxolane drug development candidate Nature 2004 430 900-904 
Wang X Dong Y Wittlin S Creek D Chollet J Charman SA Tomas JS Scheurer C Snyder C Vennerstrom JL Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides J Med Chem 2007 50 5840-5847 
Wei N Sadrzadeh SM Enhancement of hemin-induced membrane damage by artemisinin Biochem Pharmacol 1994 48 737-741 
Wiwanitkit V Plasmodium and host glutathione reductase: molecular function and biological process Afr J Biotechnol 2006 5 2009-2013 
Zhou L Alker A Ruf A Wang X Chiu FC Morizzi J Charman SA Charman WN Scheurer C Wittlin S Dong Y Hunziker D Vennerstrom JL Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277 Bioorg Med Chem Lett 2008 18 1555-1558 
